Referenser

  1. Trinchieri A. Epidemiology of urolithiasis: an update. Clin Cases Miner Bone Metab. 2008;5(2):101-6.

  2. Ahlstrand C, Tiselius HG. Recurrences during a 10-year follow-up after first renal stone episode. Urol Res. 1990;18(6):397-9.

  3. Scales CD, Jr., Curtis LH, Norris RD, Springhart WP, Sur RL, Schulman KA, et al. Changing gender prevalence of stone disease. J Urol. 2007;177(3):979-82.

  4. Assimos DG. Re: Prevalence of Monogenic Causes in Pediatric Patients with Nephrolithiasis or Nephrocalcinosis. J Urol. 2016;196(2):550-1.

  5. Raheem OA, Khandwala YS, Sur RL, Ghani KR, Denstedt JD. Burden of Urolithiasis: Trends in Prevalence, Treatments, and Costs. Eur Urol Focus. 2017;3(1):18-26.

  6. Kravdal G, Helgø D, Moe MK. Kidney stone compositions and frequencies in a Norwegian population. Scand J Urol. 2019;53(2-3):139-44.

  7. Daudon M, Doré JC, Jungers P, Lacour B. Changes in stone composition according to age and gender of patients: a multivariate epidemiological approach. Urol Res. 2004;32(3):241-7.

  8. Gambaro G, Croppi E, Bushinsky D, Jaeger P, Cupisti A, Ticinesi A, et al. The Risk of Chronic Kidney Disease Associated with Urolithiasis and its Urological Treatments: A Review. J Urol. 2017;198(2):268-73.

  9. Daudon M, Bouzidi H, Bazin D. Composition and morphology of phosphate stones and their relation with etiology. Urol Res. 2010;38(6):459-67.

  10. Cameron MA, Sakhaee K. Uric acid nephrolithiasis. Urol Clin North Am. 2007;34(3):335-46.

  11. Flannigan R, Choy WH, Chew B, Lange D. Renal struvite stones--pathogenesis, microbiology, and management strategies. Nat Rev Urol. 2014;11(6):333-41.

  12. Bhatt NP, Deshpande AV, Starkey MR. Pharmacological interventions for the management of cystinuria: a systematic review. J Nephrol. 2024;37(2):293-308.

  13. Goldfarb DS, Avery AR, Beara-Lasic L, Duncan GE, Goldberg J. A Twin Study of Genetic Influences on Nephrolithiasis in Women and Men. Kidney Int Rep. 2019;4(4):535-40.

  14. Elliott JP, Jr., Gordon JO, Evans JW, Platt L. A stone season. A 10-year retrospective study of 768 surgical stone cases with respect to seasonal variation. J Urol. 1975;114(4):574-7.

  15. Evans K, Costabile RA. Time to development of symptomatic urinary calculi in a high risk environment. J Urol. 2005;173(3):858-61.

  16. Borghi L, Meschi T, Amato F, Briganti A, Novarini A, Giannini A. Urinary volume, water and recurrences in idiopathic calcium nephrolithiasis: a 5-year randomized prospective study. J Urol. 1996;155(3):839-43.

  17. Borghi L, Schianchi T, Meschi T, Guerra A, Allegri F, Maggiore U, et al. Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria. N Engl J Med. 2002;346(2):77-84.

  18. Asplin JR. The management of patients with enteric hyperoxaluria. Urolithiasis. 2016;44(1):33-43.

  19. Hood VL, Sternberg KM, de Waal D, Asplin JR, Mulligan C, Callas PW. Association of Urine Findings with Metabolic Syndrome Traits in a Population of Patients with Nephrolithiasis. Kidney360. 2022;3(2):317-24.

  20. Chang CW, Ke HL, Lee JI, Lee YC, Jhan JH, Wang HS, et al. Metabolic Syndrome Increases the Risk of Kidney Stone Disease: A Cross-Sectional and Longitudinal Cohort Study. J Pers Med. 2021;11(11).

  21. Spivacow FR, del Valle EE, Negri AL, Fradinger E, Abib A, Rey P. Biochemical diagnosis in 3040 kidney stone formers in Argentina. Urolithiasis. 2015;43(4):323-30.

  22. İbis MA, Oktar A, Gokce MI. Dietary advice for patients with bowel-related conditions and malabsorption. World J Urol. 2023;41(5):1235-42.

  23. Taylor EN, Stampfer MJ, Curhan GC. Diabetes mellitus and the risk of nephrolithiasis. Kidney Int. 2005;68(3):1230-5.

  24. Zreik R, Pilosov Solomon I, Saliba W, Tor R, Cohen S, Friefeld Y, et al. The relationship between patients' kidney stone type and demographics in Israel: analysis of 10 K patients. World J Urol. 2023;41(6):1641-6.

  25. Daudon M, Cohen-Solal F, Lacour B, Jungers P. [Urinary stones and urinary tract abnormalities. Is the stone composition independent of the anatomical abnormality?]. Prog Urol. 2003;13(6):1320-9. Lithiases et anomalies des voies urinaires: la composition des calculs est-elle indépendante de l'anomalie anatomique?

  26. Seitz C, Fajković H, Remzi M, Waldert M, Ozsoy M, Kramer G, et al. Rapid extracorporeal shock wave lithotripsy treatment after a first colic episode correlates with accelerated ureteral stone clearance. Eur Urol. 2006;49(6):1099-105; discussion 105-6.

  27. Nestler S, Grüne B, Schilchegger L, Neisius A, Jones J. Evaluation of stone free rates in early versus delayed primary ureteroscopy: time does matter. World J Urol. 2021;39(3):909-14.

  28. Kerr WS, Jr. Effects of complete ureteral obstruction in dogs on kidney function. Am J Physiol. 1956;184(3):521-6.

  29. Skolarikos A, Laguna MP, Alivizatos G, Kural AR, de la Rosette JJ. The role for active monitoring in urinary stones: a systematic review. J Endourol. 2010;24(6):923-30.

  30. Coll DM, Varanelli MJ, Smith RC. Relationship of spontaneous passage of ureteral calculi to stone size and location as revealed by unenhanced helical CT. AJR Am J Roentgenol. 2002;178(1):101-3.

  31. Pathan SA, Mitra B, Straney LD, Afzal MS, Anjum S, Shukla D, et al. Delivering safe and effective analgesia for management of renal colic in the emergency department: a double-blind, multigroup, randomised controlled trial. Lancet. 2016;387(10032):1999-2007.

  32. Hinojosa-Gonzalez DE, Torres-Martinez M, Villegas-De Leon SU, Galindo-Garza C, Roblesgil-Medrano A, Alanis-Garza C, et al. Emergent urinary decompression in acute stone-related urinary obstruction: A systematic review and meta-analysis. Journal of Clinical Urology. 2023;16(1):19-31.

  33. Inci K, Sahin A, Islamoglu E, Eren MT, Bakkaloglu M, Ozen H. Prospective long-term followup of patients with asymptomatic lower pole caliceal stones. J Urol. 2007;177(6):2189-92.

  34. Keeley FX, Jr., Tilling K, Elves A, Menezes P, Wills M, Rao N, et al. Preliminary results of a randomized controlled trial of prophylactic shock wave lithotripsy for small asymptomatic renal calyceal stones. BJU Int. 2001;87(1):1-8.

  35. Radecka E, Magnusson A. Complications associated with percutaneous nephrostomies. A retrospective study. Acta Radiol. 2004;45(2):184-8.

  36. Hanna B, Zhuo K, Chalasani V, Vass J, Rasiah K, Wines M, et al. Association between ureteric stent dwell time and urinary tract infection. ANZ J Surg. 2021;91(1-2):187-91.

  37. Kar M, Dubey A, Patel SS, Siddiqui T, Ghoshal U, Sahu C. Characteristics of Bacterial Colonization and Urinary Tract Infection after Indwelling of Double-J ureteral Stent and Percutaneous Nephrostomy Tube. J Glob Infect Dis. 2022;14(2):75-80.

  38. Bosio A, Alessandria E, Dalmasso E, Peretti D, Agosti S, Bisconti A, et al. How bothersome double-J ureteral stents are after semirigid and flexible ureteroscopy: a prospective single-institution observational study. World J Urol. 2019;37(1):201-7.

  39. Wagenius M, Borglin J, Popiolek M, Forsvall A, Stranne J, Linder A. Percutaneous nephrolithotomy and modern aspects of complications and antibiotic treatment. Scand J Urol. 2020;54(2):162-70.

  40. Wagenius M, Rydberg M, Popiolek M, Forsvall A, Stranne J, Linder A. Ureteroscopy: a population based study of clinical complications and possible risk factors for stone surgery. Cent European J Urol. 2019;72(3):285-95.

  41. Skolarikos A, Alivizatos G, de la Rosette J. Extracorporeal shock wave lithotripsy 25 years later: complications and their prevention. Eur Urol. 2006;50(5):981-90; discussion 90.

  42. Perez Castro E, Osther PJ, Jinga V, Razvi H, Stravodimos KG, Parikh K, et al. Differences in ureteroscopic stone treatment and outcomes for distal, mid-, proximal, or multiple ureteral locations: the Clinical Research Office of the Endourological Society ureteroscopy global study. Eur Urol. 2014;66(1):102-9.

  43. Seitz C, Desai M, Häcker A, Hakenberg OW, Liatsikos E, Nagele U, et al. Incidence, prevention, and management of complications following percutaneous nephrolitholapaxy. Eur Urol. 2012;61(1):146-58.

  44. Tokas T, Habicher M, Junker D, Herrmann T, Jessen JP, Knoll T, et al. Uncovering the real outcomes of active renal stone treatment by utilizing non-contrast computer tomography: a systematic review of the current literature. World J Urol. 2017;35(6):897-905.

  45. Prot-Bertoye C, Lebbah S, Daudon M, Tostivint I, Jais JP, Lillo-Le Louët A, et al. Adverse events associated with currently used medical treatments for cystinuria and treatment goals: results from a series of 442 patients in France. BJU Int. 2019;124(5):849-61.

  46. Tsaturyan A, Bokova E, Bosshard P, Bonny O, Fuster DG, Roth B. Oral chemolysis is an effective, non-invasive therapy for urinary stones suspected of uric acid content. Urolithiasis. 2020;48(6):501-7.

  47. Barcelo P, Wuhl O, Servitge E, Rousaud A, Pak CY. Randomized double-blind study of potassium citrate in idiopathic hypocitraturic calcium nephrolithiasis. J Urol. 1993;150(6):1761-4.

  48. Ohkawa M, Tokunaga S, Nakashima T, Orito M, Hisazumi H. Thiazide treatment for calcium urolithiasis in patients with idiopathic hypercalciuria. Br J Urol. 1992;69(6):571-6.

  49. Hoppe B, Beck BB, Milliner DS. The primary hyperoxalurias. Kidney Int. 2009;75(12):1264-71.

  50. Dolin DJ, Asplin JR, Flagel L, Grasso M, Goldfarb DS. Effect of cystine-binding thiol drugs on urinary cystine capacity in patients with cystinuria. J Endourol. 2005;19(3):429-32.

Föregående sida
Uppföljning

Nästa sida
Tillbaka till kapitlets första sida